Cataract Surgery in Behçet's Disease Patients One Week after Infliximab Administration

PURPOSE: To describe two patients with Behçet's disease who underwent cataract surgery one week after infliximab administration. METHODS: Patients received preoperative antibiotic therapy with 0.5% levofloxacin eye drops and 500 mg levofloxacin oral tablets, followed by cataract surgery one wee...

Descripción completa

Detalles Bibliográficos
Autores principales: Handa, Tsuneaki, Tsunekawa, Hinako, Zako, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2011
Materias:
Published: May 2011
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124453/
https://www.ncbi.nlm.nih.gov/pubmed/21720532
http://dx.doi.org/10.1159/000329091
Descripción
Sumario:PURPOSE: To describe two patients with Behçet's disease who underwent cataract surgery one week after infliximab administration. METHODS: Patients received preoperative antibiotic therapy with 0.5% levofloxacin eye drops and 500 mg levofloxacin oral tablets, followed by cataract surgery one week after infliximab administration. We observed ocular findings following cataract surgery, phacoemulsification-aspiration, and posterior chamber intraocular lens implantation. RESULTS: There were no intraoperative complications. Neither ocular inflammatory attacks nor infectious complications were found in the operated eyes of both patients during follow-up. CONCLUSION: Administration of infliximab one week before cataract surgery is safe and effective for patients with Behçet's disease.

Ejemplares similares